Insights

Our team members’ insights are regularly featured in policy magazines, peer-reviewed journals, and industry and trade publications on key health sector issues.

Featured Infographics

The truth about the federal drug pricing reform

Health Canada has changed the Patented Medicines Regulations to introduce strict price controls for medicines. But the reforms are based on false assumptions.

How New Medicines are Reviewed and Funded in Canada

Before patients in Canada can get access to a new innovative medicine or new use for a medicine, it must first pass through a complex review process.

How New Oncology Medicines are Reviewed and Funded in Canada

Before patients in Canada can access a new innovative oncology medicine or new use for an oncology medicine, it must first pass through a complex review process.

Publications

PHARMAFOCUS 2026 UPDATE

November 2022
Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Stephanie Levee | IQVIA

Profiles in reimbursement – The important and ever-evolving role of the pCPA

November 2022
Gerry Jeffcott | Provincial Reimbursement Advisor

Profiles in reimbursement – The important and ever-evolving role of CADTH

May 2022
Gerry Jeffcott and Don Sancton | Provincial Reimbursement Advisor

PHARMAFOCUS 2026

June 2022
Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Stephanie Levee | IQVIA

The road to national pharmacare in Canada: Where will the federal NDP-Liberal agreement take us?

August 2022
Don Sancton | Provincial Reimbursement Advisor

Oh national rare disease treatment strategy, wherefore art thou?

August 2022
Gerry Jeffcott | Provincial Reimbursement Advisor

Is Canada spending what it should on medications?

February 2022
Gerry Jeffcott | Provincial Reimbursement Advisor

The Pathway for New Cancer Drug Access in Canada

January 2022
Johanne Chambers, William Dempster, Joanna Gotfrit, Paul Whealtey-Price | Current Oncology Vol. 29(2)

Engage with confidence and a complete 3SIXTY view